Antagonists for treatment of CD/11CD18 adhesion receptor mediated disorders
申请人:Burdick J. Daniel
公开号:US20050203135A1
公开(公告)日:2005-09-15
Compounds of the general structure D-L-B-(AA), for example (A), that are useful for treating Mac-1 or LFA-1-mediated disorders such as inflammatory disorders, allergies, and autoimmune diseases are provided.